Compare Yum! Brands, Inc. (YUM) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Yum! Brands, Inc. vs Zoetis Inc — how do they compare? Yum! Brands, Inc. trades at $144.69 (market cap $39.02B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Yum! Brands, Inc. is the larger of the two by market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Yum! Brands, Inc. for 132 Days and Zoetis Inc for 70 Days on average.
| YUM | ZTS | |
|---|---|---|
Market Cap | $39.02B | $30.20B |
Volume | 2,597,636 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $168.16 | $147.53 |
52-Week Low | $135.77 | $69.09 |
Typical Hold Time | 132 Days | 70 Days |
Enterprise Value | $50.63B | $37.76B |
Dividend Yield | 2.1% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
YUM stock trades at $145.15, up 3.42% today, with a bullish technical signal and strong support at $141. Revenue grew to $8.21B in 2025, with net income of $1.56B and a 25.4% net margin. The company recently sold Pizza Hut for $1.5B, focusing on KFC and Taco Bell, and declared a $0.75 dividend payable September 18, 2026.
Outlook is positive with a consensus price target of $170.44, though high debt and competitive pressures pose risks. Earnings beat expectations in two of the last three quarters, and cash flow from operations is robust at $2.01B, supporting shareholder returns amid a hold-heavy analyst rating.
Zoetis (ZTS) trades at $74.38, up 3.96% in the last session, with a bullish technical signal and strong profitability metrics including a 71.67% gross margin and 27.69% net income margin. Recent earnings show mixed results, with a beat in Q2 2026 but a miss in Q1 2026, while Q3 2026 results are pending. The company maintains robust cash flow from operations of $2.90B in 2025 and a solid balance sheet with $1.99B in cash. Analyst consensus is a Buy with a $87.33 price target, though sentiment is tempered by near-term competitive pressures.
The outlook for ZTS is cautiously optimistic, supported by industry-leading margins and a diversified product portfolio, but faces headwinds from U.S. companion animal market weakness and increased competition. Investment opportunity lies in its undervalued P/E of 11.92 relative to growth potential, while risks include pricing erosion and volume declines. The stock's current level near resistance at $74 suggests potential for consolidation before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
